SGRY Surgery Partners, Inc.
Healthcare$13.48+0.00%OpenMarket Cap: $1.76B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.02
P/S
0.52
EV/EBITDA
5.75
DCF Value
$131.28
FCF Yield
11.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
21.7%
Operating Margin
12.3%
Net Margin
-2.3%
ROE
-4.4%
ROA
-0.9%
ROIC
4.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $810.9M | 15.0% | $82.4M | $-35.9M | $— | — |
| Q4 null | $885.0M | 24.0% | $110.2M | $-15.0M | $— | — |
| FY null | $3.31B | 23.1% | $389.5M | $-77.9M | $— | — |
| Q3 null | $821.5M | 23.8% | $105.7M | $-22.7M | $— | — |
| Q2 null | $826.2M | 23.7% | $111.7M | $-2.5M | $— | — |
| Q1 null | $776.0M | 20.9% | $61.9M | $-37.7M | $— | — |
| Q4 null | $864.4M | 27.0% | $127.1M | $-108.5M | $— | — |
| FY null | $3.11B | 23.9% | $348.8M | $-168.1M | $— | — |
| Q3 null | $770.4M | 23.0% | $60.9M | $-31.7M | $— | — |
| Q2 null | $762.1M | 23.5% | $84.8M | $-15.5M | $— | — |
| Q1 null | $717.4M | 21.6% | $76.0M | $-12.4M | $— | — |
| Q4 2023 | $735.4M | 26.3% | $101.4M | $-1.0M | $-0.01 | — |